Clearly, given the suggestion that CaSR levels might influence the likelihood of breast cancer risk, the estrogen-receptor status of tumors and/or the growth of bone metastasis, these issues need to be explored in larger studies with sufficient power to examine the different genetic sub-types of breast cancer individually. This evidence concerns the gene ESR1 and breast carcinoma.